- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/65 - Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
Patent holdings for IPC class A61K 47/65
Total number of patents in this class: 1839
10-year publication summary
|
53
|
102
|
187
|
180
|
174
|
180
|
197
|
229
|
164
|
51
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20534 |
30 |
| Daiichi Sankyo Company, Limited | 1887 |
28 |
| SeaGen Inc | 545 |
24 |
| Bicyclerd Limited | 149 |
22 |
| Bayer Pharma AG | 1029 |
20 |
| Genequantum Healthcare (Suzhou) Co., Ltd. | 78 |
20 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 676 |
18 |
| SynDevRx, Inc. | 52 |
18 |
| Cornell University | 3384 |
16 |
| Genentech, Inc. | 4065 |
15 |
| CytomX Therapeutics, Inc. | 228 |
15 |
| MedImmune Limited | 612 |
13 |
| Regeneron Pharmaceuticals, Inc. | 4593 |
13 |
| Bristol-myers Squibb Company | 4812 |
12 |
| The Johns Hopkins University | 5819 |
12 |
| Sanofi | 4237 |
12 |
| ImmunoGen, Inc. | 383 |
11 |
| Mersana Therapeutics, Inc. | 99 |
11 |
| Bio-Thera Solutions, Ltd. | 146 |
11 |
| Hoffmann-La Roche Inc. | 3686 |
10 |
| Other owners | 1508 |